| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6800685 | Journal of Psychiatric Research | 2015 | 26 Pages |
Abstract
It seems to be of importance to consider prescribing a drug with a clear anti-toxoplasmic activity (TATA+) for BD patients seropositive to T. gondii, in particular valproate that was found as the mood stabilizer with the highest antitoxoplasmic activity. Prospective randomized controlled trials are warranted to confirm this preliminary data.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Guillaume Fond, Laurent Boyer, Alexandru Gaman, Hakim Laouamri, Dodji Attiba, Jean-Romain Richard, Marine Delavest, Josselin Houenou, Philippe Le Corvoisier, Dominique Charron, Rajagopal Krishnamoorthy, José Oliveira, Ryad Tamouza, Robert Yolken,